Gender‐affirming chest surgery decisions in response to hypothetical BRCA1/2 genetic testing
Journal of Genetic Counseling · 2025
DOI: 10.1002/jgc4.70003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Genetic Counseling, 2025. Verfasst von Taylor I Gray und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Hauptthemen laut MEDLINE: Genetic Testing, Decision Making, BRCA2 Protein, BRCA1 Protein. Die Arbeit nennt 19 Literaturangaben. Gefördert von: Icahn School of Medicine at Mount Sinai.
Abstract (Originalsprache)
To align their bodies with gender identity, transgender and gender‐diverse individuals may elect to undergo gender‐affirming chest masculinization or feminization, which is different from the standard mastectomy recommended to those with BRCA1/2 pathogenic variants. This study aimed to determine if genetic testing revealing a pathogenic variant associated with a significantly higher lifetime risk of breast cancer would influence decisions regarding chest surgery type. The investigators hypothesized that BRCA1/2 pathogenic variant carrier status would influence gender‐diverse individuals to elect a more invasive surgery to address increased cancer risk. Of 26 transgender and gender‐diverse individuals without a history of chest surgery, 23.1% stated they would likely elect a more invasive surgery type based on positive genetic testing results while, of 17 individuals with a previous history of chest reconstruction, 52.9% stated it was unlikely that genetic testing would have altered their surgical decision‐making. These results suggest that health care providers should counsel transgender patients about the utility of genetic testing prior to gender‐affirming chest reconstruction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
- Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA.
- Center for Transgender Medicine and Surgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
ORCID-Profile: Taylor I Gray
Förderung
- Icahn School of Medicine at Mount Sinai
Zitieren
APA
Gray, T. I., Safer, J. D., & Zaretsky, L. (2025). Gender‐affirming chest surgery decisions in response to hypothetical BRCA1/2 genetic testing. Journal of Genetic Counseling. https://doi.org/10.1002/jgc4.70003
Vancouver
Gray TI, Safer JD, Zaretsky L. Gender‐affirming chest surgery decisions in response to hypothetical BRCA1/2 genetic testing. Journal of Genetic Counseling. 2025. doi:10.1002/jgc4.70003
BibTeX
@article{Gray2025,
author = {Gray, Taylor I and Safer, Joshua D and Zaretsky, Leah},
title = {Gender‐affirming chest surgery decisions in response to hypothetical BRCA1/2 genetic testing},
journal = {Journal of Genetic Counseling},
year = {2025},
doi = {10.1002/jgc4.70003}
}
EUVIMED